Potential impacts of GLP-1 drugs should be considered as key risks to Resmed investment thesis. However, the likely impact is overstated, or over-priced into the share price. Resmed is trading at 18 times their FY25 forecast compared to the 10-year average of 28 times.
- Forums
- ASX - By Stock
- Buy RMD now and get great upside returns in a year or two
Potential impacts of GLP-1 drugs should be considered as key...
-
- There are more pages in this discussion • 192 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RMD (ASX) to my watchlist
(20min delay)
|
|||||
Last
$32.78 |
Change
-0.320(0.97%) |
Mkt cap ! $20.91B |
Open | High | Low | Value | Volume |
$32.74 | $33.07 | $32.74 | $34.25M | 1.041M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1267 | $32.78 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$32.82 | 2077 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8686 | 32.770 |
1 | 8686 | 32.750 |
1 | 8686 | 32.730 |
2 | 682 | 32.720 |
1 | 8686 | 32.710 |
Price($) | Vol. | No. |
---|---|---|
32.870 | 8686 | 1 |
32.890 | 8686 | 1 |
32.910 | 8686 | 1 |
32.930 | 8686 | 1 |
32.950 | 9368 | 3 |
Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
Last
$32.87 |
  |
Change
-0.320 ( 0.67 %) |
|||
Open | High | Low | Volume | ||
$32.77 | $33.07 | $32.77 | 531228 | ||
Last updated 15.59pm 17/05/2024 ? |
Featured News
RMD (ASX) Chart |